Western Blot:Article Title:
Article Snippet: 3 nature portfolio | reporting sum m ary April 2023 Materials & experimental systems n/a Involved in the study Antibodies Eukaryotic cell lines Palaeontology and archaeology Animals and other organisms Clinical data Dual use research of concern Plants Methods n/a Involved in the study ChIP-seq Flow cytometry MRI-based neuroimaging Antibodies Antibodies used The following antibodies for Flow analysis were used: APC/Cyanine7-CD45 1:200 (103116, Biolegend), APC-CD3 1:200 (100236, Biolegend), PECY5.5-CD4 1:200 (100434, Biolegend), BB700-CD4 1:200 (566407, BD), PECY7-CD8 1:200 (100722, Biolegend), APC-PD-L1 1:200 (124312, Biolegend), APC-F4/80 1:200 (123116, Biolegend), APC-CD25 1:200 (102012, Biolegend), BV421-Gr-1 1:200 (108445, Biolegend), PE-Cy7-CD11b 1:200 (552850, Biolegend), PerCP-Cy5.5-MHC II 1:200 (107626, Biolegend), PE-FOXP3 1:200 (12-5773-82, eBioscience), FITC-GZMB 1:200 (372206, Biolegend), PECY594-GZMB 1:200 (372216, Biolegend), PE-CD206 1:200 (141706, Biolegend), PE-PD-L1 1:200 (329706, Biolegend). .. The following antibodies for WB analysis were used: CD40 1:2000 (A0218, ABclonal), VISTA 1:2000 (64953, Cell Signaling), PD-L2 1:2000 (82723, Cell Signaling), PVR 1:2000 (81254, Cell Signaling), CD70 1:2000 (A2032, ABclonal), CD80 1:2000 (15416, Cell Signaling), CD86 1:2000 (A19026, ABclonal), CD112 1:2000 (95333, Cell Signaling), CD276 1:2000 (A21663, ABclonal), OX40L 1:2000 (A18389, ABclonal), TNFSF14 1:2000 (A2002, ABclonal), GITRL 1:2000 (A7028, ABclonal), PD-L1 1:2000 (13684, Cell Signaling), SQSTM1/p62 1:2000 (23214, Cell Signaling), LC3A/B 1:2000 (12741, Cell Signaling), PD-L1 1:2000 (ab213524, Abcam), PD-L1 1:2000 (ab213480, Abcam), Beclin1 1:2000 (ab207612, Abcam), CPT1A 1:2000 (15184-1-AP, Proteintech), HIP1R 1:2000 (16814-1-AP, Proteintech), GAPDH 1:5000 (60004-1-Ig, Proteintech), ALAS1 1:2000 (A4817, ABclonal), TOM20 1:2000 (A19403, ABclonal), CPT1A 1:2000 (ab128568, Abcam). .. The following antibodies for IF/IHC analysis were used: Granzyme B 1:200 (ab4059, Abcam), Rab7B 1:200 (ab193360, Abcam), CD3 1:200 (ab16669, Abcam), PD-L1 1:200 (66248-1-Ig, Proteintech), TGN46 1:200 (13573-1-AP, Proteintech), CD8α 1:200 (ab217344, Abcam), Rab11B 1:100 (15903-1-AP, Proteintech), GRP94 1:200 (14700-1-AP, Proteintech), Secondary antibodies and DAPI: CY3 goat anti-rabbit IgG (GB21303, Servicebio), FITC goat anti-rabbit IgG (GB22303, Servicebio), DAPI (G1012, Servicebio), CY5 goat anti-rabbit IgG (GB27303, Servicebio).
Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma.
Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) IHC CD3 #85061 (Cell Signaling AR TIC LE IN PR ES S 90 Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) TIGIT NB2-79794 (Novus Biologicals) CD226 HPA015715 (Atlas Antibodies) CD96 HPA066754 (Atlas Antibodies) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) (Human) CD155 #81254 (Cell Signaling Technology) CD155 ab233102 (Abcam) CD112 27171-1-AP (Proteintech) CD111 24713-1-AP (Proteintech) CD113 LS-C210246 (LSBio) PCNA sc-56 (Santa Cruz Biotechnology) cleaved caspase-3 #9664 (Cell Signaling Technology) P-H2AX #9718 (Cell Signaling Technology) IHC (Mouse) Ki67 ab16667 (Abcam) CD155 #81254 (Cell Signaling Technology) CD111 sc-21722 (Santa Cruz Biotechnology) CD112 #95333 (Cell Signaling Technology) CD113 sc-69714 (Santa Cruz Biotechnology) Western Blot (Human) β-actin #4970 (Cell Signaling Technology) Western Blot CD155 ab16667 (Abcam) AR TIC LE IN PR ES S 91 CD112 ab135246 (Abcam) CD111 sc-21722 (Santa Cruz Biotechnology) CD113 sc-271611 (Santa Cruz Biotechnology) (Mouse) β-actin #4970 (Cell Signaling Technology) CD45.2-Pacific Blue clone 104 (BioLegend) CD3-APC-Cy7 clone 145-2C11 (BioLegend) TIGIT-PE clone 1G9 (BioLegend) CD96-APC clone 3.3 (BioLegend) CD226-FITC clone 10E5 (BioLegend) CD25-FITC clone PC61 (BioLegend) FOXP3-PE clone MF-14 (BioLegend) CD226-PE-Cy7 clone 10E5 (BioLegend) CD4-APC clone RM4-4 (BioLegend) CD3-APC-Cy7 clone 17A2 (BioLegend) CD45-Pacific Blue clone S18009F (BioLegend) IFN-γ-FITC clone XMG1.2 (BioLegend) IL-4-PE-Cy7 clone 11B11 (BioLegend) CD8a-PE clone 53-6.7 (BioLegend) CD107a-FITC clone 1D4B (BioLegend) Perforin-APC clone S16009A (BioLegend) CD8a-PE-Cy7 clone 53-6.7 (BioLegend) CD4-PerCP-Cy5.5 clone GK1.5 (BioLegend) Granzyme B-PE clone NGZB (eBioscience) CD155-PE clone 4.24.1 (BioLegend) Flow Cytometry (Mouse) CD112-PE clone 829038 (R&D Systems) Anti-mouse TIGIT #BE037 / clone 1G9 (Bio X Cell) Anti-mouse CD96 #BE0174 / clone 3.3 (Bio X Cell) In Vivo Treatment (Mouse) Mouse IgG1 Isotype Control #BE0083 / clone MOPC-21 (Bio X Cell) 1810 1811 1812 1813 AR TIC LE IN PR ES S 92 1814 1815 1816 1817 1818 1819 1820 1821 1822 1823 Table S2. ..
Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma.
Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) TIGIT NB2-79794 (Novus Biologicals) CD226 HPA015715 (Atlas Antibodies) CD96 HPA066754 (Atlas Antibodies) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) IHC (Human) CD155 #81254 (Cell Signaling Technology) CD155 ab233102 (Abcam) CD112 27171-1-AP (Proteintech) CD111 24713-1-AP (Proteintech) CD113 LS-C210246 (LSBio) PCNA sc-56 (Santa Cruz Biotechnology) Cleaved Caspase-3 #9664 (Cell Signaling Technology) P-H2AX #9718 (Cell Signaling Technology) IHC (Mouse) Ki67 ab16667 (Abcam) CD155 #81254 (Cell Signaling Technology) CD111 sc-21722 (Santa Cruz Biotechnology) CD112 #95333 (Cell Signaling Technology) Western Blot (Human) CD113 sc-69714 (Santa Cruz AR TIC LE IN PR ES S 2 Biotechnology) β-actin #4970 (Cell Signaling Technology) CD155 ab16667 (Abcam) CD112 ab135246 (Abcam) CD111 sc-21722 (Santa Cruz Biotechnology) CD113 sc-271611 (Santa Cruz Biotechnology) Western Blot (Mouse) β-actin #4970 (Cell Signaling Technology) CD45.2-Pacific Blue clone 104 (BioLegend) CD3-APC-Cy7 clone 145-2C11 (BioLegend) TIGIT-PE clone 1G9 (BioLegend) CD96-APC clone 3.3 (BioLegend) CD226-FITC clone 10E5 (BioLegend) CD25-FITC clone PC61 (BioLegend) FOXP3-PE clone MF-14 (BioLegend) CD226-PE-Cy7 clone 10E5 (BioLegend) CD4-APC clone RM4-4 (BioLegend) CD3-APC-Cy7 clone 17A2 (BioLegend) CD45-Pacific Blue clone S18009F (BioLegend) IFN-γ-FITC clone XMG1.2 (BioLegend) IL-4-PE-Cy7 clone 11B11 (BioLegend) CD8a-PE clone 53-6.7 (BioLegend) CD107a-FITC clone 1D4B (BioLegend) Perforin-APC clone S16009A (BioLegend) CD8a-PE-Cy7 clone 53-6.7 (BioLegend) CD4-PerCP-Cy5.5 clone GK1.5 (BioLegend) Granzyme B-PE clone NGZB (eBioscience) CD155-PE clone 4.24.1 (BioLegend) Flow Cytometry (Mouse) CD112-PE clone 829038 (R&D Systems) Anti-mouse TIGIT #BE037 / clone 1G9 (Bio X Cell) Anti-mouse CD96 #BE0174 / clone 3.3 (Bio X Cell) In Vivo Treatment (Mouse) Mouse IgG1 Isotype Control #BE0083 / clone MOPC-21 (Bio X Cell) 2 AR TIC LE IN PR ES S Table S2. ..
other:Article Title: Alterations in PD-L1 succinylation shape anti-tumor immune responses in melanoma.
Article Snippet: The following antibodies for IF/IHC analysis were used: Granzyme B 1:200 (ab4059, Abcam), Rab7B 1:200 (ab193360, Abcam), CD3 1:200 (ab16669, Abcam), PD-L1 1:200 (66248-1-Ig, Proteintech), TGN46 1:200 (13573-1-AP, Proteintech), CD8α 1:200 (ab217344, Abcam), Rab11B 1:100 (15903-1-AP, Proteintech), GRP94 1:200 (14700-1-AP, Proteintech), Secondary antibodies and DAPI: CY3 goat anti-rabbit IgG (GB21303, Servicebio), FITC goat anti-rabbit IgG (GB22303, Servicebio), DAPI (G1012, Servicebio), CY5 goat anti-rabbit IgG (GB27303, Servicebio).
Immunohistochemistry:Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma.
Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) IHC CD3 #85061 (Cell Signaling AR TIC LE IN PR ES S 90 Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) TIGIT NB2-79794 (Novus Biologicals) CD226 HPA015715 (Atlas Antibodies) CD96 HPA066754 (Atlas Antibodies) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) (Human) CD155 #81254 (Cell Signaling Technology) CD155 ab233102 (Abcam) CD112 27171-1-AP (Proteintech) CD111 24713-1-AP (Proteintech) CD113 LS-C210246 (LSBio) PCNA sc-56 (Santa Cruz Biotechnology) cleaved caspase-3 #9664 (Cell Signaling Technology) P-H2AX #9718 (Cell Signaling Technology) IHC (Mouse) Ki67 ab16667 (Abcam) CD155 #81254 (Cell Signaling Technology) CD111 sc-21722 (Santa Cruz Biotechnology) CD112 #95333 (Cell Signaling Technology) CD113 sc-69714 (Santa Cruz Biotechnology) Western Blot (Human) β-actin #4970 (Cell Signaling Technology) Western Blot CD155 ab16667 (Abcam) AR TIC LE IN PR ES S 91 CD112 ab135246 (Abcam) CD111 sc-21722 (Santa Cruz Biotechnology) CD113 sc-271611 (Santa Cruz Biotechnology) (Mouse) β-actin #4970 (Cell Signaling Technology) CD45.2-Pacific Blue clone 104 (BioLegend) CD3-APC-Cy7 clone 145-2C11 (BioLegend) TIGIT-PE clone 1G9 (BioLegend) CD96-APC clone 3.3 (BioLegend) CD226-FITC clone 10E5 (BioLegend) CD25-FITC clone PC61 (BioLegend) FOXP3-PE clone MF-14 (BioLegend) CD226-PE-Cy7 clone 10E5 (BioLegend) CD4-APC clone RM4-4 (BioLegend) CD3-APC-Cy7 clone 17A2 (BioLegend) CD45-Pacific Blue clone S18009F (BioLegend) IFN-γ-FITC clone XMG1.2 (BioLegend) IL-4-PE-Cy7 clone 11B11 (BioLegend) CD8a-PE clone 53-6.7 (BioLegend) CD107a-FITC clone 1D4B (BioLegend) Perforin-APC clone S16009A (BioLegend) CD8a-PE-Cy7 clone 53-6.7 (BioLegend) CD4-PerCP-Cy5.5 clone GK1.5 (BioLegend) Granzyme B-PE clone NGZB (eBioscience) CD155-PE clone 4.24.1 (BioLegend) Flow Cytometry (Mouse) CD112-PE clone 829038 (R&D Systems) Anti-mouse TIGIT #BE037 / clone 1G9 (Bio X Cell) Anti-mouse CD96 #BE0174 / clone 3.3 (Bio X Cell) In Vivo Treatment (Mouse) Mouse IgG1 Isotype Control #BE0083 / clone MOPC-21 (Bio X Cell) 1810 1811 1812 1813 AR TIC LE IN PR ES S 92 1814 1815 1816 1817 1818 1819 1820 1821 1822 1823 Table S2. ..
Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma.
Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) TIGIT NB2-79794 (Novus Biologicals) CD226 HPA015715 (Atlas Antibodies) CD96 HPA066754 (Atlas Antibodies) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) IHC (Human) CD155 #81254 (Cell Signaling Technology) CD155 ab233102 (Abcam) CD112 27171-1-AP (Proteintech) CD111 24713-1-AP (Proteintech) CD113 LS-C210246 (LSBio) PCNA sc-56 (Santa Cruz Biotechnology) Cleaved Caspase-3 #9664 (Cell Signaling Technology) P-H2AX #9718 (Cell Signaling Technology) IHC (Mouse) Ki67 ab16667 (Abcam) CD155 #81254 (Cell Signaling Technology) CD111 sc-21722 (Santa Cruz Biotechnology) CD112 #95333 (Cell Signaling Technology) Western Blot (Human) CD113 sc-69714 (Santa Cruz AR TIC LE IN PR ES S 2 Biotechnology) β-actin #4970 (Cell Signaling Technology) CD155 ab16667 (Abcam) CD112 ab135246 (Abcam) CD111 sc-21722 (Santa Cruz Biotechnology) CD113 sc-271611 (Santa Cruz Biotechnology) Western Blot (Mouse) β-actin #4970 (Cell Signaling Technology) CD45.2-Pacific Blue clone 104 (BioLegend) CD3-APC-Cy7 clone 145-2C11 (BioLegend) TIGIT-PE clone 1G9 (BioLegend) CD96-APC clone 3.3 (BioLegend) CD226-FITC clone 10E5 (BioLegend) CD25-FITC clone PC61 (BioLegend) FOXP3-PE clone MF-14 (BioLegend) CD226-PE-Cy7 clone 10E5 (BioLegend) CD4-APC clone RM4-4 (BioLegend) CD3-APC-Cy7 clone 17A2 (BioLegend) CD45-Pacific Blue clone S18009F (BioLegend) IFN-γ-FITC clone XMG1.2 (BioLegend) IL-4-PE-Cy7 clone 11B11 (BioLegend) CD8a-PE clone 53-6.7 (BioLegend) CD107a-FITC clone 1D4B (BioLegend) Perforin-APC clone S16009A (BioLegend) CD8a-PE-Cy7 clone 53-6.7 (BioLegend) CD4-PerCP-Cy5.5 clone GK1.5 (BioLegend) Granzyme B-PE clone NGZB (eBioscience) CD155-PE clone 4.24.1 (BioLegend) Flow Cytometry (Mouse) CD112-PE clone 829038 (R&D Systems) Anti-mouse TIGIT #BE037 / clone 1G9 (Bio X Cell) Anti-mouse CD96 #BE0174 / clone 3.3 (Bio X Cell) In Vivo Treatment (Mouse) Mouse IgG1 Isotype Control #BE0083 / clone MOPC-21 (Bio X Cell) 2 AR TIC LE IN PR ES S Table S2. ..
Flow Cytometry:Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma.
Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) IHC CD3 #85061 (Cell Signaling AR TIC LE IN PR ES S 90 Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) TIGIT NB2-79794 (Novus Biologicals) CD226 HPA015715 (Atlas Antibodies) CD96 HPA066754 (Atlas Antibodies) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) (Human) CD155 #81254 (Cell Signaling Technology) CD155 ab233102 (Abcam) CD112 27171-1-AP (Proteintech) CD111 24713-1-AP (Proteintech) CD113 LS-C210246 (LSBio) PCNA sc-56 (Santa Cruz Biotechnology) cleaved caspase-3 #9664 (Cell Signaling Technology) P-H2AX #9718 (Cell Signaling Technology) IHC (Mouse) Ki67 ab16667 (Abcam) CD155 #81254 (Cell Signaling Technology) CD111 sc-21722 (Santa Cruz Biotechnology) CD112 #95333 (Cell Signaling Technology) CD113 sc-69714 (Santa Cruz Biotechnology) Western Blot (Human) β-actin #4970 (Cell Signaling Technology) Western Blot CD155 ab16667 (Abcam) AR TIC LE IN PR ES S 91 CD112 ab135246 (Abcam) CD111 sc-21722 (Santa Cruz Biotechnology) CD113 sc-271611 (Santa Cruz Biotechnology) (Mouse) β-actin #4970 (Cell Signaling Technology) CD45.2-Pacific Blue clone 104 (BioLegend) CD3-APC-Cy7 clone 145-2C11 (BioLegend) TIGIT-PE clone 1G9 (BioLegend) CD96-APC clone 3.3 (BioLegend) CD226-FITC clone 10E5 (BioLegend) CD25-FITC clone PC61 (BioLegend) FOXP3-PE clone MF-14 (BioLegend) CD226-PE-Cy7 clone 10E5 (BioLegend) CD4-APC clone RM4-4 (BioLegend) CD3-APC-Cy7 clone 17A2 (BioLegend) CD45-Pacific Blue clone S18009F (BioLegend) IFN-γ-FITC clone XMG1.2 (BioLegend) IL-4-PE-Cy7 clone 11B11 (BioLegend) CD8a-PE clone 53-6.7 (BioLegend) CD107a-FITC clone 1D4B (BioLegend) Perforin-APC clone S16009A (BioLegend) CD8a-PE-Cy7 clone 53-6.7 (BioLegend) CD4-PerCP-Cy5.5 clone GK1.5 (BioLegend) Granzyme B-PE clone NGZB (eBioscience) CD155-PE clone 4.24.1 (BioLegend) Flow Cytometry (Mouse) CD112-PE clone 829038 (R&D Systems) Anti-mouse TIGIT #BE037 / clone 1G9 (Bio X Cell) Anti-mouse CD96 #BE0174 / clone 3.3 (Bio X Cell) In Vivo Treatment (Mouse) Mouse IgG1 Isotype Control #BE0083 / clone MOPC-21 (Bio X Cell) 1810 1811 1812 1813 AR TIC LE IN PR ES S 92 1814 1815 1816 1817 1818 1819 1820 1821 1822 1823 Table S2. ..
Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma.
Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) TIGIT NB2-79794 (Novus Biologicals) CD226 HPA015715 (Atlas Antibodies) CD96 HPA066754 (Atlas Antibodies) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) IHC (Human) CD155 #81254 (Cell Signaling Technology) CD155 ab233102 (Abcam) CD112 27171-1-AP (Proteintech) CD111 24713-1-AP (Proteintech) CD113 LS-C210246 (LSBio) PCNA sc-56 (Santa Cruz Biotechnology) Cleaved Caspase-3 #9664 (Cell Signaling Technology) P-H2AX #9718 (Cell Signaling Technology) IHC (Mouse) Ki67 ab16667 (Abcam) CD155 #81254 (Cell Signaling Technology) CD111 sc-21722 (Santa Cruz Biotechnology) CD112 #95333 (Cell Signaling Technology) Western Blot (Human) CD113 sc-69714 (Santa Cruz AR TIC LE IN PR ES S 2 Biotechnology) β-actin #4970 (Cell Signaling Technology) CD155 ab16667 (Abcam) CD112 ab135246 (Abcam) CD111 sc-21722 (Santa Cruz Biotechnology) CD113 sc-271611 (Santa Cruz Biotechnology) Western Blot (Mouse) β-actin #4970 (Cell Signaling Technology) CD45.2-Pacific Blue clone 104 (BioLegend) CD3-APC-Cy7 clone 145-2C11 (BioLegend) TIGIT-PE clone 1G9 (BioLegend) CD96-APC clone 3.3 (BioLegend) CD226-FITC clone 10E5 (BioLegend) CD25-FITC clone PC61 (BioLegend) FOXP3-PE clone MF-14 (BioLegend) CD226-PE-Cy7 clone 10E5 (BioLegend) CD4-APC clone RM4-4 (BioLegend) CD3-APC-Cy7 clone 17A2 (BioLegend) CD45-Pacific Blue clone S18009F (BioLegend) IFN-γ-FITC clone XMG1.2 (BioLegend) IL-4-PE-Cy7 clone 11B11 (BioLegend) CD8a-PE clone 53-6.7 (BioLegend) CD107a-FITC clone 1D4B (BioLegend) Perforin-APC clone S16009A (BioLegend) CD8a-PE-Cy7 clone 53-6.7 (BioLegend) CD4-PerCP-Cy5.5 clone GK1.5 (BioLegend) Granzyme B-PE clone NGZB (eBioscience) CD155-PE clone 4.24.1 (BioLegend) Flow Cytometry (Mouse) CD112-PE clone 829038 (R&D Systems) Anti-mouse TIGIT #BE037 / clone 1G9 (Bio X Cell) Anti-mouse CD96 #BE0174 / clone 3.3 (Bio X Cell) In Vivo Treatment (Mouse) Mouse IgG1 Isotype Control #BE0083 / clone MOPC-21 (Bio X Cell) 2 AR TIC LE IN PR ES S Table S2. ..
In Vivo:Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma.
Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) IHC CD3 #85061 (Cell Signaling AR TIC LE IN PR ES S 90 Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) TIGIT NB2-79794 (Novus Biologicals) CD226 HPA015715 (Atlas Antibodies) CD96 HPA066754 (Atlas Antibodies) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) (Human) CD155 #81254 (Cell Signaling Technology) CD155 ab233102 (Abcam) CD112 27171-1-AP (Proteintech) CD111 24713-1-AP (Proteintech) CD113 LS-C210246 (LSBio) PCNA sc-56 (Santa Cruz Biotechnology) cleaved caspase-3 #9664 (Cell Signaling Technology) P-H2AX #9718 (Cell Signaling Technology) IHC (Mouse) Ki67 ab16667 (Abcam) CD155 #81254 (Cell Signaling Technology) CD111 sc-21722 (Santa Cruz Biotechnology) CD112 #95333 (Cell Signaling Technology) CD113 sc-69714 (Santa Cruz Biotechnology) Western Blot (Human) β-actin #4970 (Cell Signaling Technology) Western Blot CD155 ab16667 (Abcam) AR TIC LE IN PR ES S 91 CD112 ab135246 (Abcam) CD111 sc-21722 (Santa Cruz Biotechnology) CD113 sc-271611 (Santa Cruz Biotechnology) (Mouse) β-actin #4970 (Cell Signaling Technology) CD45.2-Pacific Blue clone 104 (BioLegend) CD3-APC-Cy7 clone 145-2C11 (BioLegend) TIGIT-PE clone 1G9 (BioLegend) CD96-APC clone 3.3 (BioLegend) CD226-FITC clone 10E5 (BioLegend) CD25-FITC clone PC61 (BioLegend) FOXP3-PE clone MF-14 (BioLegend) CD226-PE-Cy7 clone 10E5 (BioLegend) CD4-APC clone RM4-4 (BioLegend) CD3-APC-Cy7 clone 17A2 (BioLegend) CD45-Pacific Blue clone S18009F (BioLegend) IFN-γ-FITC clone XMG1.2 (BioLegend) IL-4-PE-Cy7 clone 11B11 (BioLegend) CD8a-PE clone 53-6.7 (BioLegend) CD107a-FITC clone 1D4B (BioLegend) Perforin-APC clone S16009A (BioLegend) CD8a-PE-Cy7 clone 53-6.7 (BioLegend) CD4-PerCP-Cy5.5 clone GK1.5 (BioLegend) Granzyme B-PE clone NGZB (eBioscience) CD155-PE clone 4.24.1 (BioLegend) Flow Cytometry (Mouse) CD112-PE clone 829038 (R&D Systems) Anti-mouse TIGIT #BE037 / clone 1G9 (Bio X Cell) Anti-mouse CD96 #BE0174 / clone 3.3 (Bio X Cell) In Vivo Treatment (Mouse) Mouse IgG1 Isotype Control #BE0083 / clone MOPC-21 (Bio X Cell) 1810 1811 1812 1813 AR TIC LE IN PR ES S 92 1814 1815 1816 1817 1818 1819 1820 1821 1822 1823 Table S2. ..
Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma.
Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) TIGIT NB2-79794 (Novus Biologicals) CD226 HPA015715 (Atlas Antibodies) CD96 HPA066754 (Atlas Antibodies) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) IHC (Human) CD155 #81254 (Cell Signaling Technology) CD155 ab233102 (Abcam) CD112 27171-1-AP (Proteintech) CD111 24713-1-AP (Proteintech) CD113 LS-C210246 (LSBio) PCNA sc-56 (Santa Cruz Biotechnology) Cleaved Caspase-3 #9664 (Cell Signaling Technology) P-H2AX #9718 (Cell Signaling Technology) IHC (Mouse) Ki67 ab16667 (Abcam) CD155 #81254 (Cell Signaling Technology) CD111 sc-21722 (Santa Cruz Biotechnology) CD112 #95333 (Cell Signaling Technology) Western Blot (Human) CD113 sc-69714 (Santa Cruz AR TIC LE IN PR ES S 2 Biotechnology) β-actin #4970 (Cell Signaling Technology) CD155 ab16667 (Abcam) CD112 ab135246 (Abcam) CD111 sc-21722 (Santa Cruz Biotechnology) CD113 sc-271611 (Santa Cruz Biotechnology) Western Blot (Mouse) β-actin #4970 (Cell Signaling Technology) CD45.2-Pacific Blue clone 104 (BioLegend) CD3-APC-Cy7 clone 145-2C11 (BioLegend) TIGIT-PE clone 1G9 (BioLegend) CD96-APC clone 3.3 (BioLegend) CD226-FITC clone 10E5 (BioLegend) CD25-FITC clone PC61 (BioLegend) FOXP3-PE clone MF-14 (BioLegend) CD226-PE-Cy7 clone 10E5 (BioLegend) CD4-APC clone RM4-4 (BioLegend) CD3-APC-Cy7 clone 17A2 (BioLegend) CD45-Pacific Blue clone S18009F (BioLegend) IFN-γ-FITC clone XMG1.2 (BioLegend) IL-4-PE-Cy7 clone 11B11 (BioLegend) CD8a-PE clone 53-6.7 (BioLegend) CD107a-FITC clone 1D4B (BioLegend) Perforin-APC clone S16009A (BioLegend) CD8a-PE-Cy7 clone 53-6.7 (BioLegend) CD4-PerCP-Cy5.5 clone GK1.5 (BioLegend) Granzyme B-PE clone NGZB (eBioscience) CD155-PE clone 4.24.1 (BioLegend) Flow Cytometry (Mouse) CD112-PE clone 829038 (R&D Systems) Anti-mouse TIGIT #BE037 / clone 1G9 (Bio X Cell) Anti-mouse CD96 #BE0174 / clone 3.3 (Bio X Cell) In Vivo Treatment (Mouse) Mouse IgG1 Isotype Control #BE0083 / clone MOPC-21 (Bio X Cell) 2 AR TIC LE IN PR ES S Table S2. ..
Control:Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma.
Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) IHC CD3 #85061 (Cell Signaling AR TIC LE IN PR ES S 90 Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) TIGIT NB2-79794 (Novus Biologicals) CD226 HPA015715 (Atlas Antibodies) CD96 HPA066754 (Atlas Antibodies) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) (Human) CD155 #81254 (Cell Signaling Technology) CD155 ab233102 (Abcam) CD112 27171-1-AP (Proteintech) CD111 24713-1-AP (Proteintech) CD113 LS-C210246 (LSBio) PCNA sc-56 (Santa Cruz Biotechnology) cleaved caspase-3 #9664 (Cell Signaling Technology) P-H2AX #9718 (Cell Signaling Technology) IHC (Mouse) Ki67 ab16667 (Abcam) CD155 #81254 (Cell Signaling Technology) CD111 sc-21722 (Santa Cruz Biotechnology) CD112 #95333 (Cell Signaling Technology) CD113 sc-69714 (Santa Cruz Biotechnology) Western Blot (Human) β-actin #4970 (Cell Signaling Technology) Western Blot CD155 ab16667 (Abcam) AR TIC LE IN PR ES S 91 CD112 ab135246 (Abcam) CD111 sc-21722 (Santa Cruz Biotechnology) CD113 sc-271611 (Santa Cruz Biotechnology) (Mouse) β-actin #4970 (Cell Signaling Technology) CD45.2-Pacific Blue clone 104 (BioLegend) CD3-APC-Cy7 clone 145-2C11 (BioLegend) TIGIT-PE clone 1G9 (BioLegend) CD96-APC clone 3.3 (BioLegend) CD226-FITC clone 10E5 (BioLegend) CD25-FITC clone PC61 (BioLegend) FOXP3-PE clone MF-14 (BioLegend) CD226-PE-Cy7 clone 10E5 (BioLegend) CD4-APC clone RM4-4 (BioLegend) CD3-APC-Cy7 clone 17A2 (BioLegend) CD45-Pacific Blue clone S18009F (BioLegend) IFN-γ-FITC clone XMG1.2 (BioLegend) IL-4-PE-Cy7 clone 11B11 (BioLegend) CD8a-PE clone 53-6.7 (BioLegend) CD107a-FITC clone 1D4B (BioLegend) Perforin-APC clone S16009A (BioLegend) CD8a-PE-Cy7 clone 53-6.7 (BioLegend) CD4-PerCP-Cy5.5 clone GK1.5 (BioLegend) Granzyme B-PE clone NGZB (eBioscience) CD155-PE clone 4.24.1 (BioLegend) Flow Cytometry (Mouse) CD112-PE clone 829038 (R&D Systems) Anti-mouse TIGIT #BE037 / clone 1G9 (Bio X Cell) Anti-mouse CD96 #BE0174 / clone 3.3 (Bio X Cell) In Vivo Treatment (Mouse) Mouse IgG1 Isotype Control #BE0083 / clone MOPC-21 (Bio X Cell) 1810 1811 1812 1813 AR TIC LE IN PR ES S 92 1814 1815 1816 1817 1818 1819 1820 1821 1822 1823 Table S2. ..
Article Title: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma.
Article Snippet: .. List of antibodies used in this study Application Antibody Catalog / Clone No. (Company) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) CD155 #81254 (Cell Signaling Technology) CD111 HPA026846 (Atlas Antibodies) CD112 #95333 (Cell Signaling Technology) CD113 HPA011038 (Atlas Antibodies) TIGIT NB2-79794 (Novus Biologicals) CD226 HPA015715 (Atlas Antibodies) CD96 HPA066754 (Atlas Antibodies) CD3 #85061 (Cell Signaling Technology) CD57 clone TB01 (Dako) IHC (Human) CD155 #81254 (Cell Signaling Technology) CD155 ab233102 (Abcam) CD112 27171-1-AP (Proteintech) CD111 24713-1-AP (Proteintech) CD113 LS-C210246 (LSBio) PCNA sc-56 (Santa Cruz Biotechnology) Cleaved Caspase-3 #9664 (Cell Signaling Technology) P-H2AX #9718 (Cell Signaling Technology) IHC (Mouse) Ki67 ab16667 (Abcam) CD155 #81254 (Cell Signaling Technology) CD111 sc-21722 (Santa Cruz Biotechnology) CD112 #95333 (Cell Signaling Technology) Western Blot (Human) CD113 sc-69714 (Santa Cruz AR TIC LE IN PR ES S 2 Biotechnology) β-actin #4970 (Cell Signaling Technology) CD155 ab16667 (Abcam) CD112 ab135246 (Abcam) CD111 sc-21722 (Santa Cruz Biotechnology) CD113 sc-271611 (Santa Cruz Biotechnology) Western Blot (Mouse) β-actin #4970 (Cell Signaling Technology) CD45.2-Pacific Blue clone 104 (BioLegend) CD3-APC-Cy7 clone 145-2C11 (BioLegend) TIGIT-PE clone 1G9 (BioLegend) CD96-APC clone 3.3 (BioLegend) CD226-FITC clone 10E5 (BioLegend) CD25-FITC clone PC61 (BioLegend) FOXP3-PE clone MF-14 (BioLegend) CD226-PE-Cy7 clone 10E5 (BioLegend) CD4-APC clone RM4-4 (BioLegend) CD3-APC-Cy7 clone 17A2 (BioLegend) CD45-Pacific Blue clone S18009F (BioLegend) IFN-γ-FITC clone XMG1.2 (BioLegend) IL-4-PE-Cy7 clone 11B11 (BioLegend) CD8a-PE clone 53-6.7 (BioLegend) CD107a-FITC clone 1D4B (BioLegend) Perforin-APC clone S16009A (BioLegend) CD8a-PE-Cy7 clone 53-6.7 (BioLegend) CD4-PerCP-Cy5.5 clone GK1.5 (BioLegend) Granzyme B-PE clone NGZB (eBioscience) CD155-PE clone 4.24.1 (BioLegend) Flow Cytometry (Mouse) CD112-PE clone 829038 (R&D Systems) Anti-mouse TIGIT #BE037 / clone 1G9 (Bio X Cell) Anti-mouse CD96 #BE0174 / clone 3.3 (Bio X Cell) In Vivo Treatment (Mouse) Mouse IgG1 Isotype Control #BE0083 / clone MOPC-21 (Bio X Cell) 2 AR TIC LE IN PR ES S Table S2. ..
|